241 related articles for article (PubMed ID: 22158899)
21. The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
Varfolomeev E; Wayson SM; Dixit VM; Fairbrother WJ; Vucic D
J Biol Chem; 2006 Sep; 281(39):29022-9. PubMed ID: 16891304
[TBL] [Abstract][Full Text] [Related]
22. The paracaspase MALT1 in psoriasis.
Hailfinger S; Schulze-Osthoff K
Biol Chem; 2021 Nov; 402(12):1583-1589. PubMed ID: 34192836
[TBL] [Abstract][Full Text] [Related]
23. TAK1 lessens the activity of the paracaspase MALT1 during T cell receptor signaling.
Nicolau CA; Gavard J; Bidère N
Cell Immunol; 2020 Jul; 353():104115. PubMed ID: 32388054
[TBL] [Abstract][Full Text] [Related]
24. Multiple protein domains mediate interaction between Bcl10 and MALT1.
Langel FD; Jain NA; Rossman JS; Kingeter LM; Kashyap AK; Schaefer BC
J Biol Chem; 2008 Nov; 283(47):32419-31. PubMed ID: 18806265
[TBL] [Abstract][Full Text] [Related]
25. Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-κB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells.
Wu CH; Yang YH; Chen MR; Tsai CH; Cheng AL; Doong SL
PLoS One; 2018; 13(6):e0199779. PubMed ID: 29953499
[TBL] [Abstract][Full Text] [Related]
26. Function and targeting of MALT1 paracaspase in cancer.
O'Neill TJ; Tofaute MJ; Krappmann D
Cancer Treat Rev; 2023 Jun; 117():102568. PubMed ID: 37126937
[TBL] [Abstract][Full Text] [Related]
27. Protease activity of MALT1: a mystery unravelled.
Kirchhofer D; Vucic D
Biochem J; 2012 Jun; 444(2):e3-5. PubMed ID: 22574776
[TBL] [Abstract][Full Text] [Related]
28. The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation.
Kawadler H; Gantz MA; Riley JL; Yang X
Mol Cell; 2008 Aug; 31(3):415-21. PubMed ID: 18691973
[TBL] [Abstract][Full Text] [Related]
29. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
Juilland M; Thome M
Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
[TBL] [Abstract][Full Text] [Related]
30. Differential requirement for Malt1 in T and B cell antigen receptor signaling.
Ruland J; Duncan GS; Wakeham A; Mak TW
Immunity; 2003 Nov; 19(5):749-58. PubMed ID: 14614861
[TBL] [Abstract][Full Text] [Related]
31. The paracaspase MALT1: biological function and potential for therapeutic inhibition.
Jaworski M; Thome M
Cell Mol Life Sci; 2016 Feb; 73(3):459-73. PubMed ID: 26507244
[TBL] [Abstract][Full Text] [Related]
32. The Paracaspase MALT1.
Hachmann J; Salvesen GS
Biochimie; 2016 Mar; 122():324-38. PubMed ID: 26386283
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.
Mc Guire C; Elton L; Wieghofer P; Staal J; Voet S; Demeyer A; Nagel D; Krappmann D; Prinz M; Beyaert R; van Loo G
J Neuroinflammation; 2014 Jul; 11():124. PubMed ID: 25043939
[TBL] [Abstract][Full Text] [Related]
34. TRAF6 controls T cell homeostasis by maintaining the equilibrium of MALT1 scaffolding and protease functions.
O'Neill TJ; Gewies A; Seeholzer T; Krappmann D
Front Immunol; 2023; 14():1111398. PubMed ID: 36761777
[TBL] [Abstract][Full Text] [Related]
35. The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes.
Afonina IS; Van Nuffel E; Baudelet G; Driege Y; Kreike M; Staal J; Beyaert R
EMBO Rep; 2016 Jun; 17(6):914-27. PubMed ID: 27113748
[TBL] [Abstract][Full Text] [Related]
36. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.
Sun L; Deng L; Ea CK; Xia ZP; Chen ZJ
Mol Cell; 2004 May; 14(3):289-301. PubMed ID: 15125833
[TBL] [Abstract][Full Text] [Related]
37. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.
Noels H; van Loo G; Hagens S; Broeckx V; Beyaert R; Marynen P; Baens M
J Biol Chem; 2007 Apr; 282(14):10180-9. PubMed ID: 17287209
[TBL] [Abstract][Full Text] [Related]
38. Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.
Hailfinger S; Nogai H; Pelzer C; Jaworski M; Cabalzar K; Charton JE; Guzzardi M; Décaillet C; Grau M; Dörken B; Lenz P; Lenz G; Thome M
Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14596-601. PubMed ID: 21873235
[TBL] [Abstract][Full Text] [Related]
39. The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition.
Bardet M; Unterreiner A; Malinverni C; Lafossas F; Vedrine C; Boesch D; Kolb Y; Kaiser D; Glück A; Schneider MA; Katopodis A; Renatus M; Simic O; Schlapbach A; Quancard J; Régnier CH; Bold G; Pissot-Soldermann C; Carballido JM; Kovarik J; Calzascia T; Bornancin F
Immunol Cell Biol; 2018 Jan; 96(1):81-99. PubMed ID: 29359407
[TBL] [Abstract][Full Text] [Related]
40. CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis.
Van Nuffel E; Schmitt A; Afonina IS; Schulze-Osthoff K; Beyaert R; Hailfinger S
J Invest Dermatol; 2017 Mar; 137(3):569-575. PubMed ID: 27939769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
